SCL Biosciences helps biotech companies to build antibody catalogue by developing antibodies monoclonal and polyclonal against customer specified antigens.

SCL also ensure a regular supply of developed antibodies.

Fast & Timely delivery
Transparency in all interactions
Extremely competitive price

SCL capacity:

Monoclonal antibody development        : 600-700 antibodies (mAb) per year.
Polyclonal antibody development          : 1000-2000 antibodies (pAb) per year